Primary refractory B-cell lymphoblastic leukemia with extramedullary disease - a distinctive response to blinatumomab and inotuzumab ozogamicin (2019)
- Authors:
- Autor USP: ROCHA, VANDERSON GERALDO - FM
- Unidade: FM
- DOI: 10.1016/j.htct.2018.11.004
- Subjects: LEUCEMIA; HEMATOPOESE; RECIDIVA LOCAL DE NEOPLASIA; IMUNOTERAPIA; ANTICORPOS MONOCLONAIS; ANTINEOPLÁSICOS; RESULTADO DE TRATAMENTO
- Language: Inglês
- Source:
- Título do periódico: Hematology
- ISSN: 2531-1387
- Volume/Número/Paginação/Ano: TRANSFUSION AND CELL THERAPY, v. 41, n. 4, p. 356-359, 2019
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by-nc-nd
-
ABNT
SILVA, Wellington Fernandes da et al. Primary refractory B-cell lymphoblastic leukemia with extramedullary disease - a distinctive response to blinatumomab and inotuzumab ozogamicin. Hematology, v. 41, n. 4, p. 356-359, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.htct.2018.11.004. Acesso em: 22 maio 2024. -
APA
Silva, W. F. da, Marquez, G. L., Salim, R. C., & Rocha, V. G. (2019). Primary refractory B-cell lymphoblastic leukemia with extramedullary disease - a distinctive response to blinatumomab and inotuzumab ozogamicin. Hematology, 41( 4), 356-359. doi:10.1016/j.htct.2018.11.004 -
NLM
Silva WF da, Marquez GL, Salim RC, Rocha VG. Primary refractory B-cell lymphoblastic leukemia with extramedullary disease - a distinctive response to blinatumomab and inotuzumab ozogamicin [Internet]. Hematology. 2019 ; 41( 4): 356-359.[citado 2024 maio 22 ] Available from: https://doi.org/10.1016/j.htct.2018.11.004 -
Vancouver
Silva WF da, Marquez GL, Salim RC, Rocha VG. Primary refractory B-cell lymphoblastic leukemia with extramedullary disease - a distinctive response to blinatumomab and inotuzumab ozogamicin [Internet]. Hematology. 2019 ; 41( 4): 356-359.[citado 2024 maio 22 ] Available from: https://doi.org/10.1016/j.htct.2018.11.004 - Unrelated Cord Blood Transplantation for Acute Leukemia Diagnosed in the First Year of Life: Outcomes and Risk Factor Analysis
- Sickled cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation
- Chronic graft-versus-host disease features in double unit cord blood transplantation according to National Institutes of Health 2005 cGVHD Consensus criteria
- Duffy null genotype or Fy(a-b-) phenotype are more accurate than self-declared race for diagnosing benign ethnic neutropenia in Brazilian population
- Prevalence of SMIM1 c.64_80del17 homozygotes in southeastern Brazil [Carta]: the Vel-negative phenotype
- Haploidentical transplantation is associated with better overall survival when compared to single cord blood transplantation: an EBMT-Eurocord study of acute leukemia patients conditioned with thiotepa, busulfan, and fludarabine
- Current role of interferon in hairy cell leukemia therapy: a timely decision
- Impact of pregnancy on the outcomes of childbearing age women with chronic myeloid leukemia.[Carta]
- Survival among children and adults treated with granulocyte transfusions: twenty years' experience at a Brazilian blood center
- The impact of low dose busulfan on gonodal function after allogeneic hematopoietic stem cell transplantation for aplastic anemia [Carta]
Informações sobre o DOI: 10.1016/j.htct.2018.11.004 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
